Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Kv1.5 blockers(Voltage-gated potassium channel subunit Kv1.5 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H17Cl2N3O |
InChIKeyZRXWXSZEIJIKNS-QHCPKHFHSA-N |
CAS Registry935868-50-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atrial Fibrillation | Preclinical | US | 01 Feb 2017 |